CVS Health has agreed to pay $315 million to resolve allegations that it unlawfully filled medically unnecessary prescriptions for opioid painkillers, the US Justice Department announced on Tuesday. The settlement concludes a case initiated in 2024 that sought to hold the pharmacy chain operator accountable for its role in dispensing large quantities of opioids, which have been central to a nationwide addiction epidemic.
The lawsuit claimed that since October 2013, CVS violated the federal Controlled Substances Act by illegally dispensing opioids and other narcotics, and subsequently submitted false claims to federal healthcare programs like Medicare, contravening the False Claims Act.
Under the terms of the settlement, CVS will enter into an agreement with the Drug Enforcement Administration to establish procedures for monitoring and reporting potentially illegal opioid dispensing within its pharmacies. The company will also evaluate doctors suspected of illegally prescribing these substances.
Assistant US Attorney General Brett Shumate stated that the settlement mandates CVS to implement enhanced safeguards ensuring that prescriptions for opioids and other controlled substances are dispensed only when medically appropriate. CVS, in its own statement, expressed disagreement with the Justice Department's allegations and affirmed that it is not admitting wrongdoing. The company highlighted the training of its pharmacists in the safe and appropriate use of medications and expressed satisfaction in moving past the litigation.